Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Aug 11, 2026
Faraday Future Intelligent Electric (FFAI) Plunges -84.7% in 30 Days After 150:1 Reverse Split

Faraday Future Intelligent Electric (FFAI) Plunges -84.7% in 30 Days After 150:1 Reverse Split

Key Takeaways

  • Faraday Future Intelligent Electric (FFAI) shares have fallen approximately 84.7% over the last 30 days, dropping from $28.56 on July 10 to $4.37 as of August 10, 2026.
  • A 150:1 reverse stock split, effective July 24, 2026, triggered sharp selling pressure as the company moved to maintain Nasdaq listing compliance.
  • Over the last quarter, FFAI has declined roughly 92.9% from levels near $61.64 in mid-May, reflecting sustained dilution fears, persistent cash burn, and fragile investor confidence.
  • The company is pivoting toward an Embodied AI (EAI) robotics strategy and has raised $70 million in institutional financing since April, though the stock has not yet reflected positive sentiment from these initiatives.
  • Upcoming Q2 2026 earnings on August 13 represent a critical catalyst for potential stabilization or further downside.

Company Overview: Faraday Future Intelligent Electric (FFAI)

Faraday Future Intelligent Electric Inc. is a California-based company originally founded in 2014 as an electric vehicle manufacturer. Headquartered in El Segundo, the company has increasingly repositioned itself as a "Physical AI ecosystem company" focused on Embodied AI robotics. FFAI operates through two main business segments: AI Electric Vehicles and Digital Assets. Its flagship EV product is the FF 91, while the FX Super One series targets a broader market. The company's recent strategic transformation prioritizes EAI humanoid and bionic robots, alongside automotive-focused robotics, supported by a "Device, Data, EAI Brain" ecosystem model. I also checked this using Tickeron’s AI Trend Prediction Engine to gauge how the robotics pivot aligns with broader sector trends. Despite its ambitious vision, FFAI remains a pre-profit enterprise with trailing twelve-month revenue of approximately $732,000 and net losses exceeding $419 million. The company has a collaboration with Hebei Huanzhou Automobile Sales Co. for battery-electric vehicle development in the U.S. market. With a market capitalization near $11 million and approximately 288 employees, FFAI is closely watched by speculative investors drawn to its AI and robotics narrative amid a fiercely competitive and capital-intensive landscape.

Recent Stock Performance: 30 Days and the Quarter

FFAI stock has experienced an extraordinary decline over the past 30 days. Using split-adjusted closing prices, the stock fell from $28.56 on July 10, 2026, to $4.37 on August 10, 2026, representing a decline of approximately 84.7%. The selloff accelerated sharply ahead of and following the July 24 reverse stock split, with shares tumbling from the $10 range to below $5.00 within a single week. Intra-period volatility was extreme: on July 31, shares spiked to an intraday high of $9.30 before closing at $5.93, only to resume their downward trajectory in August.

The quarterly performance paints an even starker picture. From mid-May 2026, when FFAI traded near $61.64 (split-adjusted), the stock has lost roughly 92.9% of its value. The broader downtrend reflects a combination of structural financial pressures, aggressive dilution from convertible notes, and the market's recalibration of the company's risk profile as it transitions from an EV-focused narrative to a robotics-centric future. The stock's 52-week range spans from $3.675 to $457.50, underscoring the magnitude of value destruction over the past year.

Drivers Behind the 30-Day Collapse

The dominant catalyst behind FFAI's 30-day collapse was the announcement and execution of a 150:1 reverse stock split designed to regain compliance with Nasdaq's minimum bid price requirement. The reverse split, approved by shareholders at the May 22 annual meeting and finalized by the board, took effect on July 24, 2026. While reverse splits are often used to meet exchange listing standards, they can also signal financial distress, and FFAI's case was no exception. The stock plunged more than 41% in a single session following the announcement.

Underlying structural concerns amplified the selloff. The company's heavy reliance on convertible debt financing has produced significant dilution for existing shareholders. In a late-July investor update, CEO YT Jia acknowledged the lingering effects of legacy automotive debt, high-cost convertible instruments, and the risk that trading below $0.10 pre-split for ten consecutive days could have triggered delisting. Additionally, short interest represented approximately 13.5% of the public float as of mid-July, contributing to downward pressure. While the company highlighted positive developments — including $70 million in total institutional financing raised since April and record monthly robotics sales — the market focused overwhelmingly on the near-term financial risks.

Quarterly Pressures and Strategic Shift

FFAI's quarterly decline of roughly 92.9% reflects a compounding of financial, strategic, and market-structure challenges. The quarterly period began with the company trading near $61.64 following the release of Q1 2026 earnings on May 14, which showed a 62% year-over-year revenue increase to $512,000 and 148% quarter-over-quarter stockholders' equity growth. However, operating losses remained substantial at $35.9 million, and management acknowledged that full-scale vehicle production remained contingent on securing strategic funding.

Throughout the quarter, the company accelerated its pivot from electric vehicles toward EAI robotics, raising its 2026 robot shipment target from 1,000 to 1,500 units and launching new humanoid and bionic robot product lines. While the robotics business generated positive gross margins on 68 units shipped by the end of April, the revenue scale remained minimal relative to the company's cost structure. The May leadership transition — with YT Jia returning as sole Global CEO — brought renewed strategic clarity but did not halt the stock's descent. Persistent convertible note dilution, the looming reverse split, and ongoing cash burn eroded shareholder value throughout June and July. By the time the reverse split was enacted, the stock had already lost significant ground, and the post-split trading environment accelerated the decline.

What to Watch Ahead of Q2 Earnings

The immediate focus for FFAI investors is the company's Q2 2026 earnings report, scheduled for August 13, 2026. Key metrics to monitor include robotics shipment volumes, revenue growth trajectory, gross margin trends, and updated cash runway projections. Management's commentary on the pace of the EAI robotics rollout, the status of the "Built in USA" supply chain initiative, and progress toward the 1,500-unit annual shipment target will be closely scrutinized.

Beyond earnings, several factors will influence the stock's direction. The company's ability to transition from high-cost convertible debt to more sustainable long-term capital remains critical. Progress on the FX Super One vehicle program and any updates on strategic partnerships or industrial collaborations could shift sentiment. Macroeconomic considerations — including tariff policy on imported components and FCC regulations affecting robotics — also carry implications for FFAI's business model. Additionally, the company's Nasdaq compliance status and any further capital structure actions will remain central to the investment thesis. While the robotics pivot offers a differentiated narrative, execution risk, liquidity constraints, and intense competition from better-capitalized peers continue to present meaningful headwinds.

AI Trading Tools in Volatile Markets

In volatile market environments like the one currently affecting FFAI, I turn to data-driven tools for additional perspective. Tickeron’s Trending AI Robots page offers a curated view of top-performing AI-powered trading bots from a library of hundreds that actively trade thousands of tickers across diverse strategies, timeframes, and asset classes. These bots analyze technical indicators, fundamental data, and market patterns in real time, helping reduce emotional bias. Each bot varies in approach — some focus on swing trading, others on trend following or momentum — and performance metrics are transparently displayed. For those navigating the sharp moves in stocks like FFAI, exploring AI-driven trading tools can provide a structured way to evaluate conditions.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: FFAI

Contributor

Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.


FFAI in +28.36% Uptrend, advancing for three consecutive days on July 31, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where FFAI advanced for three days, in of 191 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The 50-day moving average for FFAI moved above the 200-day moving average on July 20, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Bearish Trend Analysis

The 10-day RSI Indicator for FFAI moved out of overbought territory on July 22, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 20 similar instances where the indicator moved out of overbought territory. In of the 20 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on July 24, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FFAI as a result. In of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for FFAI turned negative on July 27, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 37 similar instances when the indicator turned negative. In of the 37 cases the stock turned lower in the days that followed. This puts the odds of success at .

FFAI moved below its 50-day moving average on July 24, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for FFAI crossed bearishly below the 50-day moving average on August 05, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FFAI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

FFAI broke above its upper Bollinger Band on July 17, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for FFAI entered a downward trend on July 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.755) is normal, around the industry mean (9.154). P/E Ratio (0.263) is within average values for comparable stocks, (542.467). FFAI's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.910). FFAI has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.037). P/S Ratio (6.297) is also within normal values, averaging (11.674).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. FFAI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FFAI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

Notable companies

The most notable companies in this group are Tesla (NASDAQ:TSLA), General Motors Company (NYSE:GM), Ford Motor Company (NYSE:F), NIO Inc. (NYSE:NIO).

Industry description

Automobiles continue to be arguably the most popular form of passenger travel in the U.S., and major automobile makers have revenues and market capitalizations running into multi-billions. In recent years, the industry has been experiencing some path-breaking innovations like electric vehicles and self-driving technology. While there are long-standing companies like General Motors, Ford, and Toyota Motors operating in this space, there are also emerging/rapidly growing players like Tesla – which has had a major role in the growing popularity of the electric vehicle market. With technological advancements taking steam in the auto space, we’ve also witnessed collaborations (or talks of potential partnerships) of carmakers with tech behemoths like Google’s subsidiary, Waymo.

Market Cap

The average market capitalization across the Motor Vehicles Industry is 62.43B. The market cap for tickers in the group ranges from 3.72K to 1.31T. TSLA holds the highest valuation in this group at 1.31T. The lowest valued company is ZAPPF at 3.72K.

High and low price notable news

The average weekly price growth across all stocks in the Motor Vehicles Industry was -3%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was -22%. SEV experienced the highest price growth at 16%, while LVWR experienced the biggest fall at -33%.

Volume

The average weekly volume growth across all stocks in the Motor Vehicles Industry was -22%. For the same stocks of the Industry, the average monthly volume growth was -31% and the average quarterly volume growth was -59%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 58
Price Growth Rating: 62
SMR Rating: 93
Profit Risk Rating: 92
Seasonality Score: 10 (-100 ... +100)
View a ticker or compare two or three
FFAI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry MotorVehicles

Profile
Details
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.